Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Neurological

Tools & Techniques Diagnostics & prognostics

Seeing is Believing

| Jonathan James

Could changes in retinal blood vessels act as an early bio-marker for Alzheimer’s disease?

Research Field Cell & gene therapy

A Fighting Chance

| Neil Ebenezer

A new technique shows promising results for patients with sight loss from Leber congenital amaurosis

Research Field Neurological

Redirecting Cell Fate

| Jonathan James

A chemical cocktail of small molecules shows promise in driving neuro-regeneration.

Disease Area Neurological

Neurons Under (Astroctyic) Attack

| Jonathan James

Could manipulation of micro-RNA cross-talk between astrocytes and neuronal cells yield a new therapeutic avenue for ALS?

Tools & Techniques Diagnostics & prognostics

Biomarkers Beyond Our Wildest Dreams

| Luke Turner

Different glycosylation patterns in patients with idiopathic REM sleep behavior disorder could predict the future onset of neurodegenerative disease.

Disease Area Neurological

Breakdown Breakthrough

| Jonathan James

Exploring the link between blood brain barrier permeability and cognitive dysfunction.

Disease Area Neurological

The Fear of Fat

| Jonathan James

Obesity-induced anxiety might be caused by the accumulation of fatty senescent glial cells – and cleared by senolytics.

Disease Area Neurological

Alzheimer's Awakening

| Jonathan James

Changes in non-REM sleep may indicate early AD

Disease Area Neurological

A Neural Precedent

| Jonathan James

Interneuron activity suggests that there’s more to the story of seizure onset

Newsletter

Send me the latest from The Translational Scientist.

Sign up now

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register